2024. APR-246 enhances the anticancer effect of doxorubicin against p53-mutant AsPC-1 pancreatic cancer cells. Baghdad Science Journal. 21, 8 (Aug. 2024), 2551. DOI:https://doi.org/10.21123/bsj.2024.10135.